Oncology sponsors may want to use the FDA's new framework for determining the treatment-related symptoms to assess in clinical trials. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
